We are live on ! Find out more
NXTC icon

NextCure
NXTC

17 hedge funds and large institutions have $5.03M invested in NextCure in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 11 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

28.93% more ownership

Funds ownership: 3.13% → 32.06% (+29%)

11% less capital invested

Capital invested by funds: $5.65M → $5.03M (-$621K)

43% less funds holding

Funds holding: 30 → 17 (-13)

82% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 11

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 13

Holders
17
Holders Change
-13
Holders Change %
-43.33%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
11
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
P
Pfizer
New York
+$756K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.98K

Top Sellers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
-$447K
2
Renaissance Technologies
Renaissance Technologies
New York
-$70.2K
3
Macquarie Group
Macquarie Group
Australia
-$69K
4
ACM
ADAR1 Capital Management
Texas
-$54.3K
5
AC
Armistice Capital
New York
-$47.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
SI
1
Sofinnova Investments
California
$1.3M -$5 -1 -0%
AAA
2
Affinity Asset Advisors
New York
$1.12M -$5 -1 -0%
P
3
Pfizer
New York
$924K +$756K +144,509 +1,100%
Vanguard Group
4
Vanguard Group
Pennsylvania
$398K -$24.5K -4,685 -6%
CCC
5
Cable Car Capital
California
$370K – – –
Acadian Asset Management
6
Acadian Asset Management
Massachusetts
$213K -$21.1K -4,028 -10%
BlackRock
7
BlackRock
New York
$182K -$1.3K -249 -0.8%
Renaissance Technologies
8
Renaissance Technologies
New York
$166K -$70.2K -13,411 -32%
CPA
9
Cardiff Park Advisors
California
$128K – – –
Geode Capital Management
10
Geode Capital Management
Massachusetts
$114K +$1.98K +379 +2%
SCM
11
Sio Capital Management
New York
$64.1K -$10 -2 -0%
Barclays
12
Barclays
United Kingdom
$33K -$5 -1 -0%
UBS Group
13
UBS Group
Switzerland
$3.52K -$2.22K -424 -41%
JP Morgan Chase
14
JP Morgan Chase
New York
$357 -$10 -2 -3%
BNP Paribas Financial Markets
15
BNP Paribas Financial Markets
France
$188 – – –
Bank of America
16
Bank of America
North Carolina
$134 – – –
Citigroup
17
Citigroup
New York
$6 -$447K -85,455 -100%
Macquarie Group
18
Macquarie Group
Australia
– -$69K -12,500 Closed
ACM
19
ADAR1 Capital Management
Texas
– -$54.3K -9,834 Closed
AC
20
Armistice Capital
New York
– -$47.8K -8,667 Closed
State Street
21
State Street
Massachusetts
– -$30.1K -5,449 Closed
Citadel Advisors
22
Citadel Advisors
Florida
– -$27.1K -4,904 Closed
Northern Trust
23
Northern Trust
Illinois
– -$21.8K -3,958 Closed
VCIM
24
Velan Capital Investment Management
Georgia
– -$20.7K -3,750 Closed
IC
25
IEQ Capital
California
– -$17.2K -3,112 Closed
1
2

NXTC Hedge Fund Activity: Q3 2025 in Review

17 of the 7,629 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q3 2025, worth a combined $5.03M — down 11% from $5.65M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of NXTC and 0 opened new positions — a net loss of 13 holders — while 11 trimmed existing stakes and 2 added.

The largest buyer was Pfizer, adding an estimated $756K. The largest seller was Citigroup, cutting an estimated $447K.

  • 17 institutional investors held NextCure (NXTC) as of Q3 2025, down from 30 in Q2 2025.
  • Funds reported $5.03M of NextCure stock for Q3 2025, down 11% quarter-over-quarter.
  • 0 funds opened new NextCure positions in Q3 2025 and 13 closed out, a net change of -13 holders.
  • The largest NextCure buyer in Q3 2025 was Pfizer, an estimated $756K added.
  • The largest NextCure seller in Q3 2025 was Citigroup, an estimated $447K sold.

Based on aggregated 13F filings for Q3 2025.